Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BTK |
| Variant | C481R |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | BTK C481R lies within the protein kinase domain of the Btk protein (UniProt.org). C481R confers a loss of function to the Btk protein as indicated by altered enzymatic activity in an in vitro assay (PMID: 27571029), decreased kinase activity in culture (PMID: 27282255), and decreased autophosphorylation and downstream signaling in culture (PMID: 27282255). |
| Associated Drug Resistance | |
| Category Variants Paths |
BTK mutant BTK C481X BTK C481R BTK mutant BTK inact mut BTK C481R |
| Transcript | NM_000061.3 |
| gDNA | chrX:g.101356177A>G |
| cDNA | c.1441T>C |
| Protein | p.C481R |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000061 | chrX:g.101356177A>G | c.1441T>C | p.C481R | RefSeq | GRCh38/hg38 |
| NM_000061.2 | chrX:g.101356177A>G | c.1441T>C | p.C481R | RefSeq | GRCh38/hg38 |
| NM_000061.3 | chrX:g.101356177A>G | c.1441T>C | p.C481R | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| BTK C481R | diffuse large B-cell lymphoma | resistant | Ibrutinib | Preclinical - Cell culture | Actionable | In a preclinical study, diffuse large B-cell lymphoma cell lines expressing BTK C481R demonstrated resistance to Imbruvica (ibrutinib) in culture (PMID: 36183831). | 36183831 |